Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff S Higgins

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2019
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinomaDaniel R McGowan, Michael Skwarski, Kevin M Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2023
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical ModelsGonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo, et al.
Journal of the National Cancer Institute|November 11, 2017
The Future of RadiobiologyDavid G Kirsch, Max Diehn, Aparna H Kesarwala, et al.
Science Advances|June 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapyGonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung CancerMichael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Cancer Research Communications|August 21, 2024
The Proteogenomics of Prostate Cancer RadioresistanceRoni Haas, Gavin Frame, Shahbaz Khan, et al.
Journal of Medicinal Chemistry|February 23, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta"Martin L Stockley, Giovanni Benedetti, Peter Blencowe, et al.
BMC Medicine|January 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meetingMartina A McAteer, Daniel R McGowan, Gary J R Cook, et al.
Nature Communications|June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2019
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinomaDaniel R McGowan, Michael Skwarski, Kevin M Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2023
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical ModelsGonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo, et al.
Journal of the National Cancer Institute|November 11, 2017
The Future of RadiobiologyDavid G Kirsch, Max Diehn, Aparna H Kesarwala, et al.
Science Advances|June 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapyGonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung CancerMichael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Cancer Research Communications|August 21, 2024
The Proteogenomics of Prostate Cancer RadioresistanceRoni Haas, Gavin Frame, Shahbaz Khan, et al.
Journal of Medicinal Chemistry|February 23, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta"Martin L Stockley, Giovanni Benedetti, Peter Blencowe, et al.
BMC Medicine|January 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meetingMartina A McAteer, Daniel R McGowan, Gary J R Cook, et al.
Nature Communications|June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.
Pageof 6